Samuel Agresta
No más puestos en curso
Fortuna: 1 $ al 31/01/2024
Historial de carrera de Samuel Agresta
Antiguos cargos conocidos de Samuel Agresta.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| FOGHORN THERAPEUTICS INC. | Director Técnico/Científico/I+D | 01/09/2019 | 11/09/2023 |
| INFINITY PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 16/10/2019 | 24/07/2023 |
| Director Técnico/Científico/I+D | 07/08/2018 | 16/10/2019 | |
| AGIOS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/12/2011 | 01/08/2018 |
| MERRIMACK PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/11/2010 | 01/12/2011 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Director Técnico/Científico/I+D | 01/11/2007 | 01/12/2010 |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Corporate Officer/Principal | 01/08/2004 | 01/11/2010 |
Formación de Samuel Agresta.
| Georgetown University | Undergraduate Degree |
| Tulane University School of Medicine | Doctorate Degree |
| Tulane University School of Public Health & Tropical Medicine | Graduate Degree |
| University of South Florida | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 11 |
Operativa
| Chief Tech/Sci/R&D Officer | 5 |
| Graduate Degree | 2 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 5 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Commercial Services |
- Bolsa de valores
- Insiders
- Samuel Agresta
- Experiencia